Ketoconazole Hasco (Ketoconazole)

Ketoconazole blocks the fungal enzyme lanosterol 14α‑demethylase, a cytochrome P450 isoform essential for converting lanosterol to ergosterol. Without ergosterol, the fungal cell membrane becomes defective, leading to impaired growth and cell death.

The specific dose of ketoconazole is determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and other individual factors. Only a qualified health professional should set the dosage regimen.

Ketoconazole’s pregnancy category is unknown, and safety data are limited. Because potential risks to the fetus or infant cannot be ruled out, it should only be used during pregnancy or lactation if the expected benefit justifies the possible risk, and after consulting a healthcare provider.

To request Ketoconazole Hasco, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoconazole belongs to the azole class, which inhibits ergosterol synthesis. Compared with polyenes (e.g., amphotericin B) that bind directly to ergosterol, azoles are oral, generally better tolerated, and have a broader spectrum against yeasts and dermatophytes, but they may interact with more drugs via CYP enzymes.

Ketoconazole Hasco should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. This helps maintain potency and prevents degradation throughout its shelf life.

Ketoconazole Hasco is taken orally, usually with food or a full glass of water to improve absorption and reduce gastrointestinal irritation. The exact administration schedule is defined by the prescriber and should be followed precisely.

The most serious risks include hepatotoxicity, which can present as jaundice or elevated liver enzymes, severe skin reactions such as Stevens‑Johnson syndrome, QT interval prolongation leading to cardiac arrhythmias, adrenal insufficiency, and rare anaphylactic reactions. Prompt medical attention is required if any of these occur.

Ketoconazole should be avoided in patients with known hypersensitivity to azole antifungals, those with pre‑existing severe liver disease, individuals taking strong CYP3A4 inhibitors, and patients with a history of QT prolongation or serious cardiac arrhythmias unless closely monitored.